No Data
No Data
Disc Medicine Initiated at Overweight by Wells Fargo
Disc Medicine Price Target Announced at $75.00/Share by Wells Fargo
Wells Fargo Initiates Disc Medicine(IRON.US) With Buy Rating, Announces Target Price $75
Optimistic Outlook on Disc Medicine's Pipeline and Investment Potential
Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Natera (NTRA) and Disc Medicine (IRON)
Companies Like Disc Medicine (NASDAQ:IRON) Are In A Position To Invest In Growth
The Real Wojak : Do you have like a top 3-5 that you like more than all the other ones? This list is way too long
72991267 : Glad I have some $Candel Therapeutics (CADL.US)$ after my disastrous SBFM.
Rana Hasan1 : List too long